Risk Factors of Severity and Health Outcomes in COVID-19 in Ajman
Abstract
Background: Coronavirus disease 2019 (COVID-19) is an ongoing pandemic that has affected people from all over the world within the span of a few months.
Objective: To assess the association between sociodemographic factors and risk factors with disease severity and health outcomes of patients with COVID-19.
Design: This was an observational, cross-sectional and record-based study that involved 148 patients admitted to Thumbay Hospital Ajman during May-July 2020.
Results: Of the 148 participants, 39.9% were above 40 years old and 81.1% were males. 25% of the participants had diabetes mellitus and 14.2% had hypertension. Older patients (39%, n = 23) as well as those with diabetes mellitus (40.5%, n = 15) or hypertension (57.2%, n = 12) experienced significantly more severe disease courses. The same groups also experienced worse health outcomes (12.5%; n = 7, 16.7%; n = 6 and 20%; n = 4 respectively). However, there was no significant association between other sociodemographic variables such as gender, marital status and alcohol intake or smoking with disease severity or health outcomes. Similarly, the disease severity was not found to be higher among patients with dyslipidaemia or pre-existing lung conditions and they had similar health outcomes to those without these comorbidities.
Conclusion: Old age, diabetes mellitus, and hypertension are associated with significantly higher disease severity and worse health outcomes following COVID-19. Further studies are suggested to provide a clearer picture regarding the factors that predict COVID-19 outcome.
How to cite this article:
Bagakot FS, Saleem NM, Dairawan M, Sharbatti SAI. Risk Factors of Severity and Health Outcomes in COVID-19 in Ajman. Special Issue - COVID-19 & Other Communicable Disease. 2022;157-164.
DOI: https://doi.org/10.24321/0019.5138.202225
References
He F, Deng Y, Li W. Coronavirus disease 2019: What we know? J Med Virol. 2020 Jul;92(7):719-25. [PubMed] [Google Scholar]
Johns Hopkins Coronavirus Resource Center [Internet]. COVID-19 Map; 2020 [cited 2020 Jul 25]. Available from: https://coronavirus.jhu.edu/map.html
Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: a review. Clin Immunol. 2020 Jun;215:108427. [PubMed] [Google Scholar]
Liu Y, Mao B, Liang S, Yang JW, Lu HW, Chai YH, Wang L, Zhang L, Li QH, Zhao L, He Y. Association between age and clinical characteristics and outcomes of COVID-19. Eur Respir J. 2020;55(5):2001112. [Google Scholar]
Wortham JM, Lee JT, Althomsons S, Latash J, Davidson A, Guerra K, Murray K, McGibbon E, Pichardo C, Toro B, Li L, Paladini M, Eddy ML, Reilly KH, McHugh L, Thomas D, Tsai S, Ojo M, Rolland S, Bhat M, Hutchinson K, Sabel J, Eckel S, Collins J, Donovan C, Cope A, Kawasaki B, McLafferty S, Alden N, Herlihy R, Barbeau B, Dunn AC, Clark C, Pontones P, McLafferty ML, Sidelinger DE, Krueger A, Kollmann L, Larson L, Holzbauer S, Lynfield R, Westergaard R, Crawford R, Zhao L, Bressler JM, Read JS, Dunn J, Lewis A, Richardson G, Hand J, Sokol T, Adkins SH, Leitgeb B, Pindyck T, Eure T, Wong K, Datta D, Appiah GD, Brown J, Traxler R, Koumans EH, Reagan-Steiner S. Characteristics of persons who died with COVID-19 - United States, February 12-May 18, 2020. MMWR Morb Mortal Wkly Rep. 2020 Jul;69(28):923-9. [PubMed] [Google Scholar]
Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, Liu S, Yang JK. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health. 2020 Apr;8:152. [PubMed] [Google Scholar]
Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019â€nCoV) in Wuhan, China. J Med Virol. 2020 Apr;92(4):441-7. [PubMed] [Google Scholar]
Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW; the Northwell COVID-19 Research Consortium; Barnaby DP, Becker LB, Chelico JD, Cohen SL, Cookingham J, Coppa K, Diefenbach MA, Dominello AJ, Duer-Hefele J, Falzon L, Gitlin J, Hajizadeh N, Harvin TG, Hirschwerk DA, Kim EJ, Kozel ZM, Marrast LM, Mogavero JN, Osorio GA, Qiu M, Zanos TP. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020 May;323(20):2052-9. [PubMed] [Google Scholar]
Petrilli CM, Jones SA, Yang J, Rajagopalan H, O’Donnell L, Chernyak Y, Tobin KA, Cerfolio RJ, Francois F, Horwitz LI. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020 May;369:m1966. [PubMed] [Google Scholar]
World Health Organization [Internet]. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19); 2020 [cited 2020 Jul 25]. Available from: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf
Lark.com [Internet]. Lark is leading on COVID-19; [cited 2020 Jul 25]. Available from: https://www.lark.com/blog/coronavirus-and-hypertension/#ref_cah
Zhang J, Wu J, Sun X, Xue H, Shao J, Cai W, Jing Y, Yue M, Dong C. Association of hypertension with the severity and fatality of SARS-CoV-2 infection: a meta-analysis. Epidemiol Infect. 2020 May;148:e106.[PubMed] [Google Scholar]
Zhou X, Zhu J, Xu T. Clinical characteristics of coronavirus disease 2019 (COVID-19) patients with hypertension on renin–angiotensin system inhibitors. Clin Exp Hypertens. 2020 Oct;42(7):656-60. [PubMed] [Google Scholar]
Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, Bi Z, Zhao Y. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020 May;109(5):531-8. [PubMed] [Google Scholar]
Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, Akdis CA, Gao YD. Clinical characteristics of 140 patients infected with SARSâ€CoVâ€2 in Wuhan, China. Allergy. 2020 Jul;75(7):1730-41. [PubMed] [Google Scholar]
Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020 Apr;8(4):e21. [PubMed] [Google Scholar]
ARDS Definition Task Force; Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS. Acute respiratory distress syndrome. JAMA. 2012 Jun;307(23):2526-33. [PubMed] [Google Scholar]
World Health Organization [Internet]. Clinical management of COVID-19; 2020; [cited 2020 Jul 25]. Available from: https://www.who.int/publications/i/item/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected
Nachtigall I, Lenga P, Jóźwiak K, Thürmann P, Meier-Hellmann A, Kuhlen R, Brederlau J, Bauer T, Tebbenjohanns J, Schwegmann K, Hauptmann M. Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study. CMI. 2020 Dec;26(12):1663-9. [Google Scholar]
Liang WH, Guan WJ, Li CC, Li YM, Liang HR, Zhao Y, Liu XQ, Sang L, Chen RC, Tang CL, Wang T, Wang W, He QH, Chen ZS, Wong SS, Zanin M, Liu J, Xu X, Huang J, Li JF, Ou LM, Cheng B, Xiong S, Xie ZH, Ni ZY, Hu Y, Liu L, Shan H, Lei CL, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Cheng LL, Ye F, Li SY, Zheng JP, Zhang NF, Zhong NS, He JX. Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China. Eur Respir J. 2020 Jun;55(6):2000562.[PubMed] [Google Scholar]
Department of Health [Internet]. COVID-19; 2021 [cited 2021 Feb 28]. Available from: https://www.doh.gov.ae/covid-19
Horwitz LI, Jones SA, Cerfolio RJ, Francois F, Greco J, Rudy B, Petrilli CM. Trends in COVID-19 risk-adjusted mortality rates. J Hosp Med. 2021 Feb;16(2):90-2. [PubMed] [Google Scholar]
Montecino-Rodriguez E, Berent-Maoz B, Dorshkind K. Causes, consequences, and reversal of immune system aging. J Clin Invest. 2013 Mar;123(3):958-65. [PubMed] [Google Scholar]
Weng N. Aging of the immune system: how much can the adaptive immune system adapt? Immunity. 2006 May;24(5):495-9. [PubMed] [Google Scholar]
Riddle MC, Buse JB, Franks PW, Knowler WC, Ratner RE, Selvin E, Wexler DJ, Kahn SE. COVID-19 in people with diabetes: urgently needed lessons from early reports. Diabetes Care. 2020 Jul;43(7):1378-81. [PubMed] [Google Scholar]
Hariyanto TI, Kurniawan A. Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection. Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1463-5. [PubMed] [Google Scholar]
Choi GJ, Kim HM, Kang H. The potential role of dyslipidemia in COVID-19 severity: an umbrella review of systematic reviews. J Lipid Atheroscler. 2020 Sep;9(3):435-48. [PubMed] [Google Scholar]
Centers for Disease Control and Prevention [Internet]. Certain medical conditions and risk for severe COVID-19 illness; 2021 [cited 2021 May 18]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html
May BF. COVID-19 hospitalization, severity risk may not be higher in patients with asthma [Internet]. Pulmonology Advisor; 2020 [cited 2021 May 18]. Available from: https://www.pulmonologyadvisor.com/home/topics/asthma/covid-19-hospitalization-severity-risk-may-not-be-higher-in-patients-with-asthma/
Andersen C, Murphy K, Fernandez M. Impact of obesity and metabolic syndrome on immunity. Adv Nutr. 2016 Jan;7(1):66-75. [PubMed] [Google Scholar]
Milner J, Beck M. The impact of obesity on the immune response to infection. Proc Nutr Soc. 2012 May;71(2):298-306. [PubMed] [Google Scholar]
Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, Li Q, Jiang C, Zhou Y, Liu S, Ye C, Zhang P, Xing Y, Guo H, Tang W. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020 Aug;81(2):e16-e25. [PubMed] [Google Scholar]
Hu L, Chen S, Fu Y, Gao Z, Long H, Ren HW, Zuo Y, Wang J, Li H, Xu QB, Yu WX, Liu J, Shao C, Hao JJ, Wang CZ, Ma Y, Wang Z, Yanagihara R, Deng Y. Risk factors associated with clinical outcomes in 323 COVID-19 hospitalized patients in Wuhan, China. Clin Infect Dis. 2020 Nov;71(16):2089-98. [PubMed] [Google Scholar]
World Health Organization [Internet]. Coronavirus disease (COVID-19): tobacco; 2020 [cited 2020 May 27]. Available from: https://www.who.int/news-room/q-a-detail/coronavirus-disease-covid-19-tobacco
World Health Organization [Internet]. Smoking and COVID-19; 2020 [cited 2020 Jun 30]. Available from: https://www.who.int/news-room/commentaries/detail/smoking-and-covid-19
Salah HM, Sharma T, Mehta J. Smoking doubles the mortality risk in COVID-19: a meta-analysis of recent reports and potential mechanisms. Cureus. 2020 Oct;12(10):e10837. [PubMed] [Google Scholar]
Alcohol.org [Internet]. Coronavirus (COVID-19) & alcoholism; [cited 2021 Dec 20]. Available from: https://www.alcohol.org/resources/coronavirus-and-alcoholism/
Ojo A, Akin-Onitolo A, Okediji P, Balogun S. COVID-19 and alcoholism: a dangerous synergy? J Contemp Stud Epidemiol Public Health. 2020;1(1):ep20002. [Google Scholar]
Copyright (c) 2022 Author's
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
